2026 Artemetrx State of Specialty Spend and Trend Report
PSG announces the results of the industry’s go-to report on specialty drug spend and trend. With specialty drug costs remaining a top concern…
Read Post
Insights
Categories
Topics
Categories
Topics
The Great Pain Cream Scheme: How PSG Saved a Client $1.6M & Prevented Fraud
Prescription fraud, waste, and abuse (FWA) costs consumers and payers hundreds of millions of dollars. According to the Pharmaceutical Care Management Association, typical examples…
Read Post
The Opioid Epidemic: How Employers Can Offer Help and Hope
CBS News anchor Angela Kennecke last spoke to her daughter on Mother’s Day. Three days later, 21-year-old Emily died from fentanyl poisoning. Ironically, Kennecke had been…
Read Post
2018 State of Specialty Spend & Trend Report: Managing the High Cost of Specialty Drugs
The high cost of specialty drugs to treat inflammatory disorders, cancer, multiple sclerosis, and other serious illnesses continues to be a critical issue for…
Read Post
Insights into the2019 PBM Formulary Changes
The “Big 3” Pharmacy Benefit Managers (OptumRx, Express Scripts, CVS Caremark) released updates to their 2019 formulary exclusions and this year’s changes come with…
Read Post
From Prescriber to Point-of-Sale: How Employer Plan Sponsors and PBMs Are Fighting the War on Opioid Abuse
Nobody is immune from the effects of opioid misuse. A tragic number succumb to fatal overdoses—one every 13 minutes. Addiction also leaves its mark…
Read Post
A Nation in Crisis: Causes and Effects of the Ongoing Opioid Epidemic
On October 26, 2017, the President declared the opioid crisis a national public health emergency under federal law. Six short months later, the bipartisan…
Read Post
Navigating Drug Pricing Trends in a PBM Contract
In recent years, the United States healthcare system has taken a huge hit due to the astronomical increase in drug prices. To get to…
Read Post
Three Areas of Drug Benefit Waste That Could Be Costing You Millions
As a… ahem… “seasoned” pharmacist and consultant I’ve seen a lot in my time. Historically plan sponsors have had to be highly vigilant with…
Read Post
Why a Price Cut in Pcsk9 Inhibitors Isn’t Entirely Good News for Plan Sponsors
Recently it was announced that Regeneron and Sanofi had entered into an agreement with Express Scripts to drastically reduce the price tag on Praulent,…
Read Post
Manged Care Innovator: Jane Lutz
Issue: March 2018 – FRMC PSG’s Pharmacy Benefit Management Institute (PBMI) is an independent research and education organization that focuses on the complexities…
Read Post
Highlights from PBMI’s 2018 Trends in Specialty Drug Benefits Report
Understanding Why Cost Concerns Continue For the last 7 years, PSG’s Pharmacy Benefit Management Institute (PBMI) has produced original research focused on specialty drug…
Read Post